CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect

CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect

Bibliographic Details
Main Authors: Mingyue Liu, Xu Wang, Xuexiang Du, Yan Zhang, Chunxia Ai, Siwen Hu-Lieskovan, Tianhong Li, Martin Devenport, Yang Liu, Pan Zheng
Format: Article
Language:English
Published: Nature Publishing Group 2022-07-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-022-01030-x
Description
ISSN:2059-3635

Similar Items